Form 13-F position report

ONCTERNAL THERAPEUTICS INC

Reported by GEODE CAPITAL MANAGEMENT LLC

ONCT CUSIP 68236P206 Manager CIK 0001214717

Reported 25,879 shares, unchanged from the prior quarter.

Reported value -82.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q3 2024
Shares 25,879 Quarter-end amount reported
Reported value $34,164 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 216746
2024-06-30 196711
2024-09-30 34164
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for ONCTERNAL THERAPEUTICS INC held by GEODE CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -25,879 (-100.0%) 0 $0 2025-02-12
Q3 2024 Unchanged 25,879 0 (0.0%) < 0.01% $34,164 2024-11-12
Q2 2024 Added 25,879 +1,800 (7.5%) < 0.01% $196,711 2024-08-09
Q1 2024 New 24,079 +24,079 (0.0%) < 0.01% $216,746 2024-05-13

Who else reported the position

29 managers reported ONCTERNAL THERAPEUTICS INC for Q3 2024.

Managers reporting ONCTERNAL THERAPEUTICS INC in Q3 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 139,884 -3,159 < 0.01% $184,647 3 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 61,205 -41,731 < 0.01% $80,791 3 qtrs
BlackRock Inc New 39,706 +39,706 < 0.01% $52,412 1 qtr
GEODE CAPITAL MANAGEMENT LLC This report Unchanged 25,879 0 < 0.01% $34,164 3 qtrs
Pasadena Private Wealth LLC Unchanged 25,000 0 < 0.01% $33,000 2 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 17,905 +700 < 0.01% $23,635 3 qtrs
MORGAN STANLEY Reduced 14,152 -915 < 0.01% $18,681 3 qtrs
Quantum Private Wealth LLC Reduced 13,187 -13,715 < 0.01% $17,407 3 qtrs
Virtu Financial LLC New 12,276 +12,276 < 0.01% $16,000 1 qtr
Tower Research Capital LLC TRC Added 2,822 +2,201 < 0.01% $3,725 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2024
Filed
November 12, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
25,879
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.